跳至主要内容
临床试验/NCT00125125
NCT00125125已完成4 期

Efficacy and Tolerability of Fluvastatin in Adults With Dislipidemia With History of Muscle Problems Due to Other Previous Statin Intake

Novartis3 个研究点 分布在 2 个国家目标入组 218 人开始时间: 2005年5月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Novartis
入组人数
218
试验地点
3
主要终点
Change from baseline in low density lipoprotein cholesterol after 12 weeks

研究概览

简要总结

The purpose of the study is to find a good therapy for patients who need to be treated for high cholesterol and who have difficulty tolerating other statins (such as pravastatin, simvastatin, lovastatin, atorvastatin, rosuvastatin) due to muscle pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Dyslipidemia
  • History of Myalgia

排除标准

  • Previous treatment with fluvastatin
  • Age < 18 years
  • Other protocol-defined inclusion and exclusion criteria may apply.

结局指标

主要结局

Change from baseline in low density lipoprotein cholesterol after 12 weeks

次要结局

  • Number of patients who reach target LDL after 12 weeks
  • Change from baseline in total cholesterol, triglycerides, high density lipoprotein cholesterol, and lipoprotein subtypes after 12 weeks
  • Tolerability as assessed by muscle-related adverse events, and muscle-related adverse events leading to discontinuation
  • Change from baseline in marker of inflammation after 12 weeks

研究者

发起方
Novartis
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验